New Medicine Chair Honours Phil Gold
When Vassilios Papadopoulos, McGill professor and director of the Research Institute of the McGill University Health Centre (RI MUHC), learned that he had been named the Dr. Phil Gold Chair in Medicine, he was deeply touched. The Chair, one of the first of a series created jointly by McGill and the MUHC, honours the work of Phil Gold, BSc’57, MDCM’61, MSc’61, PhD’65, professor of Medicine, Physiology and Oncology and executive director of the Clinical Research Centre at the MUHC. Gold served as physician-in-chief at the Montreal General Hospital and chair of the Department of Medicine at McGill from 1985 to 1990. He was also the inaugural director of what is now the Rosalind and Morris Goodman Cancer Research Centre.
Gold is not only an inspiration for Papadopoulos, he is also an esteemed colleague. “We have very close interactions because he’s head of the clinical research centre at the MUHC,” says Papadopoulos. “He is a wonderful individual and a wonderful advisor.” As the Dr. Phil Gold Chair, Papadopoulos will continue to strengthen the ties between the academic research centres and the hospitals, and facilitate the recruitment of the best and brightest clinicians and researchers. The new position will also allow Papadopoulos to continue his research in pharmacology and understanding diseases related to abnormalities in steroid synthesis, on top of his work as director of the RI MUHC.
Papadopoulos was instrumental to the Canada Foundation for Innovation’s landmark 2008 grant of $100 million to build and equip the RI MUHC at the Glen Campus. He has published over 200 peer-reviewed manuscripts, written two books and contributed chapters for 40 more. He currently holds three grants from the National Institutes of Health and two from the Canadian Institutes of Health Research as principal investigator and is an elected member of the National Academy of Medicine in France and a fellow of the American Association for the Advancement of Science in the United States.